Clinical Trial Update: This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports completion of a Phase 1/2 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of MET097 in adults with overweigh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• MET097

Snippet

Sponsor: Metsera, a wholly owned subsidiary of Pfizer | Conditions: Obesity and Overweight | Phase 1, Phase 2 | Status: COMPLETED